Compare, Analyse AMAR REMEDIES with HYPERMARCAS SA - Brazil - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs HYPERMARCAS (Brazil) - Comparison Results

HYPERMARCAS (Brazil)
   Change

Hypermarcas SA is a leading consumer goods company in Brazil. The company is present in pharmaceuticals and personal care. The company's pharmaceuticals products include over-the-counter medications, generic drugs and prescription medications. The c... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AMAR REMEDIES   HYPERMARCAS
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
HYPERMARCAS
Dec-14
AMAR REMEDIES/
HYPERMARCAS
5-Yr Chart
Click to enlarge
High Rs164313-   
Low Rs86229-   
Sales per share (Unadj.) Rs261.6106.9-  
Earnings per share (Unadj.) Rs17.49.4-  
Cash flow per share (Unadj.) Rs22.311.9-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs100.7170.7-  
Shares outstanding (eoy) m26.16635.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.52.5 18.8%   
Avg P/E ratio x7.228.8 24.9%  
P/CF ratio (eoy) x5.622.8 24.6%  
Price / Book Value ratio x1.21.6 78.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m3,270172,180 1.9%   
No. of employees `000NA12.9 0.0%   
Total wages/salary Rs m1633,321 4.9%   
Avg. sales/employee Rs ThNM5,246.2-  
Avg. wages/employee Rs ThNM256.7-  
Avg. net profit/employee Rs ThNM461.8-  
INCOME DATA
Net Sales Rs m6,84467,860 10.1%  
Other income Rs m211,146 1.8%   
Total revenues Rs m6,86569,006 9.9%   
Gross profit Rs m1,13116,378 6.9%  
Depreciation Rs m1281,588 8.1%   
Interest Rs m3988,642 4.6%   
Profit before tax Rs m6267,294 8.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-145 34.5%   
Tax Rs m1211,175 10.3%   
Profit after tax Rs m4555,974 7.6%  
Gross profit margin %16.524.1 68.5%  
Effective tax rate %19.316.1 120.0%   
Net profit margin %6.68.8 75.5%  
BALANCE SHEET DATA
Current assets Rs m4,90469,963 7.0%   
Current liabilities Rs m3,58143,341 8.3%   
Net working cap to sales %19.339.2 49.3%  
Current ratio x1.41.6 84.8%  
Inventory Days Days12452 241.0%  
Debtors Days Days100121 82.6%  
Net fixed assets Rs m1,68924,172 7.0%   
Share capital Rs m26276,314 0.3%   
"Free" reserves Rs m2,3580-   
Net worth Rs m2,635108,402 2.4%   
Long term debt Rs m50744,573 1.1%   
Total assets Rs m6,862201,376 3.4%  
Interest coverage x2.61.8 139.5%   
Debt to equity ratio x0.20.4 46.8%  
Sales to assets ratio x1.00.3 296.0%   
Return on assets %12.47.3 171.3%  
Return on equity %17.35.5 313.3%  
Return on capital %31.010.3 300.3%  
Exports to sales %4.00-   
Imports to sales %00-   
Net fx Rs m2710-   
CASH FLOW
From Operations Rs m-3139,628 -3.2%  
From Investments Rs m-489989 -49.4%  
From Financial Activity Rs m769-887 -86.6%  
Net Cashflow Rs m-339,731 -0.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for HYPERMARCAS (Brazil) is Brazil Reais. All data has been converted at 14.5 Rs / BRL

Compare AMAR REMEDIES With: P&G (US)  UNILEVER PLC. (UK)  

Compare AMAR REMEDIES With: BAJAJ CONSUMER CARE  GILLETTE INDIA  GODREJ INDUSTRIES  BATA INDIA  EMAMI LTD  



Today's Market

Sensex Crashes 1,203 Points; IT and Banking Stocks Witness Selling(Closing)

Indian share markets extended losses in the first trading session of FY21, as the number of coronavirus cases in the country continued to rise.

Related Views On News

Most Popular

If I Were to Recommend One Stock Amid Coronavirus Outbreak, This Would be It. (Profit Hunter)

Mar 19, 2020

Coronavirus outbreak has made no impact on the long term prospects of my favourite smallcap. What it has indeed done is brought the company below my buy price, making it even more attractive investment at current price.

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020 (The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

Why India Will Be the Biggest Winner in a Post-Coronavirus World (The 5 Minute Wrapup)

Mar 19, 2020

The way businesses operate will change in a major way post the coronavirus impact. Here's why India stands to benefit from this change...

A Big Trading Opportunity is Coming Your Way Soon (Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock (Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

How to Trade the Coronavirus Crash - Download this FREE Report Now
How to Profit Even During These Times of Crisis: Vijay Bhambwani Reveals his Strategy...
The Best Stocks For 2020 - How to Spot Multibagger Ideas. FREE Sign up!
Free Report: The Secret to Increasing Your Trading Profits Daily!
Find Out Our Top 7 Bluechips for 2020 Virtually FREE. Click Here Now!

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AMAR REMEDIES

AMAR REMEDIES - LINC PEN & PLASTICS COMPARISON

COMPARE AMAR REMEDIES WITH

OTHER USEFUL LINKS

MARKET STATS